Biomerica Stock Probability of Future Stock Price Finishing Over 18.32
| BMRA Stock | USD 0.39 0.07 21.88% |
Biomerica |
Biomerica Target Price Odds to finish over 18.32
The tendency of Biomerica Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 18.32 or more in 90 days |
| 0.39 | 90 days | 18.32 | close to zero percent |
Based on a normal probability distribution, the odds of Biomerica to move over $ 18.32 or more in 90 days from now is close to zero percent (This Biomerica probability density function shows the probability of Biomerica Stock to fall within a particular range of prices over 90 days) . Probability of Biomerica price to stay between its current price of $ 0.39 and $ 18.32 at the end of the 90-day period is about 11.3 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.93 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biomerica will likely underperform. Additionally Biomerica has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biomerica Price Density |
| Price |
Predictive Modules for Biomerica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biomerica. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biomerica Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biomerica is not an exception. The market had few large corrections towards the Biomerica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biomerica, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biomerica within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.72 | |
β | Beta against Dow Jones | 1.93 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.11 |
Biomerica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biomerica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biomerica can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biomerica generated a negative expected return over the last 90 days | |
| Biomerica has high historical volatility and very poor performance | |
| Biomerica has some characteristics of a very speculative penny stock | |
| Biomerica has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 5.42 M. Net Loss for the year was (5.98 M) with profit before overhead, payroll, taxes, and interest of 446 K. | |
| Biomerica currently holds about 6.08 M in cash with (5.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biomerica has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Biomerica Secures Three Key International Patents for inFoods T |
Biomerica Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biomerica Stock often depends not only on the future outlook of the current and potential Biomerica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biomerica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.8 M | |
| Cash And Short Term Investments | 4.2 M |
Biomerica Technical Analysis
Biomerica's future price can be derived by breaking down and analyzing its technical indicators over time. Biomerica Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomerica. In general, you should focus on analyzing Biomerica Stock price patterns and their correlations with different microeconomic environments and drivers.
Biomerica Predictive Forecast Models
Biomerica's time-series forecasting models is one of many Biomerica's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biomerica's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biomerica
Checking the ongoing alerts about Biomerica for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biomerica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biomerica generated a negative expected return over the last 90 days | |
| Biomerica has high historical volatility and very poor performance | |
| Biomerica has some characteristics of a very speculative penny stock | |
| Biomerica has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 5.42 M. Net Loss for the year was (5.98 M) with profit before overhead, payroll, taxes, and interest of 446 K. | |
| Biomerica currently holds about 6.08 M in cash with (5.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biomerica has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Biomerica Secures Three Key International Patents for inFoods T |
Check out Biomerica Backtesting, Biomerica Valuation, Biomerica Correlation, Biomerica Hype Analysis, Biomerica Volatility, Biomerica History as well as Biomerica Performance. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.327 | Quarterly Revenue Growth 0.055 | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.